Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer

  1. Moutafi, M.K.
  2. Molero, M.
  3. Martinez Morilla, S.
  4. Baena, J.
  5. Vathiotis, I.A.
  6. Gavrielatou, N.
  7. Castro-Labrador, L.
  8. de Garibay, G.R.
  9. Adradas, V.
  10. Orive, D.
  11. Valencia, K.
  12. Calvo, A.
  13. Montuenga, L.M.
  14. Ponce Aix, S.
  15. Schalper, K.A.
  16. Herbst, R.S.
  17. Paz-Ares, L.
  18. Rimm, D.L.
  19. Zugazagoitia, J.
Journal:
Journal for immunotherapy of cancer

ISSN: 2051-1426

Year of publication: 2022

Volume: 10

Issue: 8

Type: Article

DOI: 10.1136/JITC-2022-004757 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus